FNY Investment Advisers »

Inhibrx Biosciences shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $0 33 0.00

More positions owned by FNY Investment Advisers

Brookfield Corp Cl A Ltd Vt Sh (BN)
Proshares Tr Bitcoin Strate (BITO)
National Western Life (NWLI)
Ralph Lauren Corp (RL)
Broadcom (AVGO)
Byrna Technologies (BYRN)
Liberty Media Corp Delaware (LSXMK)
Merck & Co (MRK)
BHP Billiton (BHP)
Asml Holding Adr Rep Ord Sponsored Adr (ASML)
Michael Kors Holdings Ord (CPRI)
Astrazeneca Plc Ord (AZNCF)
Enovix Corp (ENVX)
Hubspot (HUBS)
Nuvei Corporation (NVEI)

View all positions for FNY Investment Advisers

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences